Pharmanutra S.p.A. (761.F)
Frankfurt · EUR · Healthcare · Drug Manufacturers - Specialty & Generic
€70.50 (+1.59%) as of
Key statistics
- Market cap
- 675.05M
- P/E (TTM)
- 33.25
- EPS (TTM)
- 2.12
- Dividend yield
- 1.71%
- 52-week range
- 43.75 – 94.00
- Beta
- 0.18
- Revenue (TTM)
- 143.7M
- Profit margin
- 14.44%
- Volume
- 5.00
About Pharmanutra S.p.A.
Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for muscle and joint recovery in physiotherapy and sports. The company also sells instrumentation and software for body bioimpedance analysis through agents, distributors, and online sales. Pharmanutra S.p.A. was founded in 2000 and is headquartered in Pisa, Italy.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Pisa, PI, Italy
- Employees
- 144
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.